Shai N. Gozani, M.D., Ph.D, President and Chief Executive Officer of
NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on
the treatment and management of the neurological complications of
diabetes, was interviewed live on the TuDiabetes.org website yesterday,
March 6, 2014. TuDiabetes.org is a community of people touched by
diabetes and is a program of the Diabetes Hands Foundation.
During the live interview, Dr. Gozani provided answers to a range of
questions from the TuDiabetes.org community about the diagnosis and
treatment of diabetic peripheral neuropathy or DPN. Additionally, he
discussed a range of available tests such as the company’s DPNCheck®
device, a rapid, accurate, and quantitative point-of-care test for
diabetic neuropathy, as well as various treatment options including the
company’s SENSUS™ Pain Management System for treating chronic
intractable pain such as painful diabetic neuropathy.
To view the interview in its entirety, please visit the following link: http://www.youtube.com/watch?v=JK0I0dbZRdw
About NeuroMetrix
NeuroMetrix is a medical device company that develops and markets home
use and point-of-care devices for the treatment and management of
chronic pain, peripheral neuropathies, and associated neurological
disorders. The Company is presently focused on diabetic neuropathies,
which affect over 50% of people with diabetes. If left untreated,
diabetic neuropathies trigger foot ulcers that may require amputation
and cause disabling chronic pain. The annual cost of diabetic
neuropathies has been estimated at $14 billion in the United States. The
company markets the SENSUS™ Pain Management System for
treating chronic pain, focusing on physicians managing patients with
painful diabetic neuropathy. The company also markets the DPNCheck®
device, which is a rapid, accurate, and quantitative point-of-care test
for diabetic neuropathy. This product is used to detect diabetic
neuropathy at an early stage and to guide treatment. For more
information, please visit http://www.DPNCheck.com.
Copyright Business Wire 2014